ZW5989A1 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZW5989A1
ZW5989A1 ZW59/89A ZW5989A ZW5989A1 ZW 5989 A1 ZW5989 A1 ZW 5989A1 ZW 59/89 A ZW59/89 A ZW 59/89A ZW 5989 A ZW5989 A ZW 5989A ZW 5989 A1 ZW5989 A1 ZW 5989A1
Authority
ZW
Zimbabwe
Prior art keywords
inhibitors
concerns novel
heterocyclic compounds
heterocyclic
nitromethane derivatives
Prior art date
Application number
ZW59/89A
Other languages
English (en)
Inventor
Paul Brown Steven
Loren Cooper Anthony
Lawrence Longridge Jethro
James Morris Jeffrey
Preston John
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZW5989A1 publication Critical patent/ZW5989A1/xx

Links

Classifications

    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10BORGANS, HARMONIUMS OR SIMILAR WIND MUSICAL INSTRUMENTS WITH ASSOCIATED BLOWING APPARATUS
    • G10B3/00Details or accessories
    • G10B3/12Keys or keyboards; Manuals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Multimedia (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Air Bags (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Detergent Compositions (AREA)
  • Pyridine Compounds (AREA)
ZW59/89A 1988-04-29 1989-04-28 Heterocyclic compounds ZW5989A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888810203A GB8810203D0 (en) 1988-04-29 1988-04-29 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ZW5989A1 true ZW5989A1 (en) 1990-01-03

Family

ID=10636116

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW59/89A ZW5989A1 (en) 1988-04-29 1989-04-28 Heterocyclic compounds

Country Status (20)

Country Link
US (1) US5102905A (fr)
EP (1) EP0340010B1 (fr)
JP (1) JPH01316355A (fr)
KR (1) KR900016937A (fr)
CN (1) CN1037339A (fr)
AT (1) ATE110378T1 (fr)
AU (1) AU623128B2 (fr)
DD (1) DD283817A5 (fr)
DE (1) DE68917634D1 (fr)
DK (1) DK200889A (fr)
FI (1) FI892038L (fr)
GB (2) GB8810203D0 (fr)
HU (1) HUT49868A (fr)
MW (1) MW1389A1 (fr)
NO (1) NO891707L (fr)
NZ (1) NZ228915A (fr)
PT (1) PT90395B (fr)
ZA (1) ZA892597B (fr)
ZM (1) ZM1889A1 (fr)
ZW (1) ZW5989A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93178A0 (en) * 1989-02-03 1990-11-05 Ici Plc Benzheterocyclyl sulphones
US5250570A (en) * 1990-08-02 1993-10-05 Imperial Chemical Industries Plc Amidobenzene derivatives, compositions and use
GB9016978D0 (en) * 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
NZ254550A (en) * 1992-09-28 1997-08-22 Pfizer Use of nitrogen-substituted pyrimidines to prepare medicaments useful for treatment or prevention of diabetic complications
AU3162695A (en) * 1994-08-03 1996-03-04 Asta Medica Aktiengesellschaft Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
JP3314938B2 (ja) * 1995-06-06 2002-08-19 ファイザー・インコーポレーテッド グリコーゲンホスホリラーゼ抑制剤としての置換されたn−(インドール−2−カルボニル)−グリシンアミド類および誘導体
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
KR102229001B1 (ko) * 2018-05-31 2021-03-17 주식회사 엘지화학 신규한 화합물 및 이를 이용한 유기 발광 소자
CN110551015B (zh) * 2018-05-31 2022-06-21 株式会社Lg化学 化合物及利用其的有机发光元件

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053633A (en) * 1976-06-24 1977-10-11 The Dow Chemical Company Aryl dibromonitromethyl sulfones
US4670470A (en) * 1979-08-15 1987-06-02 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4309554A (en) * 1980-04-28 1982-01-05 The Dow Chemical Company 3-(2-Thiophenesulfonyl)-2-halopropanenitriles
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
EP0252640B1 (fr) * 1986-06-30 1991-03-06 Merck & Co. Inc. Alcanesulfonamides comme agents antiglaucome
GB8718619D0 (en) * 1987-08-06 1987-09-09 Ici Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
NO891707D0 (no) 1989-04-25
AU3308089A (en) 1989-11-02
CN1037339A (zh) 1989-11-22
ZA892597B (en) 1989-12-27
PT90395A (pt) 1989-11-10
JPH01316355A (ja) 1989-12-21
NO891707L (no) 1989-10-30
GB8906822D0 (en) 1989-05-10
AU623128B2 (en) 1992-05-07
GB8810203D0 (en) 1988-06-02
ATE110378T1 (de) 1994-09-15
DE68917634D1 (de) 1994-09-29
US5102905A (en) 1992-04-07
FI892038A0 (fi) 1989-04-28
EP0340010A3 (fr) 1991-05-15
DK200889A (da) 1989-10-30
EP0340010A2 (fr) 1989-11-02
PT90395B (pt) 1995-03-31
HUT49868A (en) 1989-11-28
FI892038A7 (fi) 1989-10-30
DD283817A5 (de) 1990-10-24
NZ228915A (en) 1991-12-23
FI892038L (fi) 1989-10-30
KR900016937A (ko) 1990-11-14
MW1389A1 (en) 1989-12-13
EP0340010B1 (fr) 1994-08-24
DK200889D0 (da) 1989-04-25
ZM1889A1 (en) 1990-01-26

Similar Documents

Publication Publication Date Title
AU643489B2 (en) Antibacterial agents - II
GR3003378T3 (en) Process for the synthesis of 3-thio-4-quinolone derivatives and intermediate compounds for use therein, and their use as medicaments
EP0614913A3 (fr) Dérivés de la dynorphine.
IL85328A (en) Pharmaceutical compositions containing 2,3-dihydroxy- (phenyl, pyridyl or cyclohexenanyl)- quinoxaline derivatives, their preparation and certain novel such quinoxalines
GB8906822D0 (en) Heterocyclic compounds
MY103595A (en) (arylsulphonyl) nitromethanes, process for their preparation and use in pharmaceutical compositions
IL86462A0 (en) Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
CA2058398A1 (fr) Derives d'acide 1,4-benzothiazine-2-acetique; methode de preparation
GB2227745B (en) Phenylsulphone derivatives
IL77051A0 (en) Novel crystalline form of benzothiazine dioxide salt and pharmaceutical compositions containing it
GR3018711T3 (en) (p-Carbonylaminophenyl)-sulphonyl-nitromethane derivatives
DE3464915D1 (en) (5-(2-aminomethyl-imidazol-1-yl)-1,3-dialkyl-1h-pyrazol-4-yl)(aryl)methanones and processes for their production
AU2639388A (en) 2-cyano-2-aryl-1-(azole-1-yl)- ethane derivatives
AU553765B2 (en) Biologically active heterocyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof